Bionano Genomics' Chinese Original Equipment Manufacturing Partner, A-smart Medtech Has Obtained Reagent Class I Registrations From China's National Medical Products Administration For Bionano's DNA Extraction Kit And Labeling Products

Bionano Genomics' Chinese Original Equipment Manufacturing Partner, A-smart Medtech Has Obtained Reagent Class I Registrations From China's National Medical Products Administration For Bionano's DNA E

BenzingaAug 28, 2023 20:03

Newtek Business Services Corp. to Report Third Quarter 2022 Financial Results on Monday, November 7, 2022 After the Market Closes

Globe NewswireOct 21, 2022 20:35

Head-To-Head Review: Emerald (NYSE:EEX) & Newtek Business Services (NASDAQ:NEWT)

Emerald (NYSE:EEX – Get Rating) and Newtek Business Services (NASDAQ:NEWT – Get Rating) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the t

Defense WorldOct 21, 2022 13:51

HRnetGroup's Profit Set to Rise as Labor Markets Recover -- Market Talk

0824 GMT - HRnetGroup's profit will likely grow as the labor markets in Singapore and China rebound, CGS-CIMB says. Citing the Singapore-listed recruitment company's expectations, the broker say

Dow Jones NewswiresNov 22, 2021 16:30

Behind the Yushun Electronics acquisition case: the plant operation avoids the efforts of "wearing a hat" to come to naught again.

On November 3, according to the official website of the CSRC, the acquisition and restructuring of SZ.002289, a subsidiary of China Plant system, was rejected, while China Plant's plan to help Yushun avoid taking off its cap by injecting assets once again failed. "the applicant fails to fully explain the core competitiveness of the underlying assets, and goodwill accounts for a large proportion after the completion of the transaction, which is not conducive to improving the quality of listed companies." The Securities and Futures Commission said. The failure of the restructuring case is likely to make Yushun face "ST" again. According to the third quarterly report, Yushun's net profit in the first three quarters is-16 million yuan. This means that in the future, no.

華爾街見聞Nov 4, 2021 22:10

Press Release: GCP Applied Technologies Reports -2-

GCP remains committed to maintaining a disciplined approach to capital allocation and preserving the Company's strong balance sheet. GCP's cash balance at the end of the third quarter 2021 was $481

Dow Jones NewswiresNov 3, 2021 18:01